Lexi-Comp Inc., a company based in Hudson that provides drug information and clinical content for pharmacists and clinicians, has agreed to be acquired.
The buyer is Philadelphia-based Wolters Kluwer Health, itself a provider of information and business intelligence for professionals, students and institutions in medicine, nursing, allied health and pharmacy. Wolters Kluwer Health is part of Wolters Kluwer, a Dutch company that is a global information service concern.
“Wolters Kluwer Health has focused heavily on building a robust suite of clinical decision support solutions for point-of-care use by health care professionals, and our acquisition of Lexi-Comp is very much aligned with this strategy,” Arvind Subramanian, president and CEO of Wolters Kluwer Health Clinical Solutions, said in a statement.Wolters Kluwer Health did not say what it will pay for Lexi-Comp, a company with about 150 employees that provides drug information and medical reference content to more than 1,500 hospitals internationally and publishes drug monographs or descriptions of drug content and use covering more than 1,700 products.
Recent Comments